References:
1. World Health Organization. Rolling Updates on Coronavirus disease
(COVID-19). World Health Oraganization. [Online] World Health
Organization, December 31, 2019. [Cited: April 06, 2020.]
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
2. Worldometer. COVID-19 Coronavirus Pandemic. Worldometer. [Online]
Worldometer, April 06, 2020. [Cited: April 06, 2020.]
https://www.worldometers.info/coronavirus/.
3. Niforatos JD, Melnick ER, Faust JS. Covid-19 fatality is likely
overestimated. BMJ. 2020 Mar 20;368:m1113. doi: 10.1136/bmj.m1113.
4. Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E.
2020, Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly
E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a
furin-like cleavage site absent in CoV of the same clade. Antiviral Res.
2020;176:104742. doi:10.1016/j.antiviral.
5. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z,Fang M,
Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and
outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan,
China: a single-centered, retrospective, observational study. Lancet
Respir Med. 2020 Feb 24. [Epub ahead of print] doi:
10.1016/S2213-2600(20)30079-5.
6. Chen C., Zhang X.R., Ju Z.Y., He W.F. Advances in the research of
cytokine storm mechanism induced by Corona virus disease 2019 and the
corresponding immunotherapies. Chin. J. Burns. Zhonghua Shao Shang Za
Zhi. 2020 Mar 1;36(0):E005. doi: 10.3760/cma.j.cn501120-20200224-00088,
Vol. 36. E005.
7. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier
B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honoré S, Colson P,
Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results
of an open-label non-randomized clinical trial. Int J Antimicrob Agents.
2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. [Epub
ahead of print].
8. Beigelman A, Bacharier LB, Baty J, Buller R, Mason S, Schechtman KB,
Sajol G, Isaacson-Schmid M, Castro M, Storch GA. Does azithromycin
modify viral load during severe respiratory syncytial virus
bronchiolitis? J Allergy Clin Immunol. 2015;136(4):1129–1131.
doi:10.1016/j.jaci.2015.06.011.
9. Zhao Q, Tensfeldt TG, Chandra R, Mould DR. Population
pharmacokinetics of azithromycin and chloroquine in healthy adults and
paediatric malaria subjects following oral administration of fixed-dose
azithromycin and chloroquine combination tablets. Malar J. 2014 Jan
29;13:36. doi: 10.1186/1475-2875-13-36.
10. Li Y, Bai WZ, Hashikawa T. J. Response to Commentary on: ”The
neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory
failure of COVID-19 patients”. Med Virol. 2020 Apr 4. doi:
10.1002/jmv.25824. [Epub ahead of print].
11. Dodd RY, Stramer SL. COVID-19 and Blood Safety: Help with a Dilemma.
Transfus Med Rev. 2020 Feb 26. pii: S0887-7963(20)30015-8. doi:
10.1016/j.tmrv.2020.02.004. [Epub ahead of print].
12. Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based
drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell
Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection
2020.
13. Boga JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ.
Beneficial actions of melatonin in the management of viral infections: a
new use for this ”molecular handyman”? Rev Med Virol. 2012
Sep;22(5):323-38, Vol. 22, pp. 323-38.
14. Silvestri M, Rossi GA. Melatonin: its possible role in the
management of viral infections–a brief review. Ital J Pediatr 2013,
Vol. 39, p. 61.
15. Vielma JR, Bonilla E, Chacín-Bonilla L, Mora M, Medina-Leendertz S,
Bravo Y. Effects of melatonin on oxidative stress, and resistance to
bacterial, parasitic, and viral infections: a review. Acta Trop 2014,
Vol. 137, pp. 31-8.
16. Habtemariam S, Daglia M, Sureda A, Selamoglu Z, Gulhan MF, Nabavi
SM. Melatonin and Respiratory Diseases: A Review. Curr Top Med Chem
2017, Vol. 17, pp. 467-488.
17. Srinivasan V, Mohamed M, Kato H. Melatonin in bacterial and viral
infections with focus on sepsis: a review. Recent Pat. Endocr. Metab.
Immune Drug Discov, 2012, Vol. 6, pp. 30–39.
18. Tan DX, Korkmaz A, Reiter RJ, Manchester LC. Ebola virus disease:
potential use of melatonin as a treatment. J. Pineal Res. 2014 Vol. 57,
pp. 381–384.
19. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One
molecule, many derivatives: a never-ending interaction of melatonin with
reactive oxygen and nitrogen species? J. Pineal Res. 2007 Vol. 42, pp.
28–42.
20. Galano A, Tan DX, Reiter RJ. On the free radical scavenging
activities of melatonin’s metabolites, AFMK and AMK. J. Pineal Res. 2013
Vol. 54, pp. 245–257.
21. Bolmatov D, McClintic WT, Taylor G, Stanley CB, Do C, Collier CP,
Leonenko Z, Lavrentovich MO, Katsaras J. Deciphering
Melatonin-Stabilized Phase Separation in Phospholipid Bilayers.
Langmuir. 2019, Vol. 35, pp. 12236-12245.
22. Gitto E, Reiter RJ, Amodio A, Romeo C, Cuzzocrea E, Sabatino G, et
al. Early indicators of chronic lung disease in infant with respiratory
distress syndrome and their inhibition by melatonin. J Pineal Res. 2005
Vol. 39, pp. 287-93.
23. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi S,
et al. Effects of melatonin treatment in septic newborns. Pediatr Res.
2001, Vol. 50, pp. 756-60.
24. Bourne RS, Mills GH, Minelli C. Melatonin therapy to improve
nocturnal sleep in critically ill patients : Encouraging results from a
small randomized controlled trial. Crit Care. 2008, Vol. 12, p. R52.
25. Valero N, Mosquera J, Alcocer S, Bonilla E, Salazar J, Álvarez-Mon
M. Melatonin, minocycline and ascorbic acid reduce oxidative stress and
viral titers and increase survival rate in experimental Venezuelan
equine encephalitis. Brain Res. 2015 Oct 5;1622:368-76. doi:
10.1016/j.brainres.2015.06.034. Epub 2015 Jul 10.
26. Hung SW. Minocycline-induced acute eosinophilic pneumonia: A case
report and review of the literature. Respir Med Case Rep. 2015 May
30;15:110-4. doi: 10.1016/j.rmcr.2015.05.013. eCollection 2015.
27. Midgley CM, and The COVID-19 Investigation Team. First 12 patients
with coronavirus disease 2019 (COVID-19) in the United States.
[Online] [Cited: April 06, 2020.]
https://www.medrxiv.org/content/10.1101/2020.03.09.20032896v1.full.pdf.
28. Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based
drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell
Discov, 2020 Vol. 6, p. 14.